beta-thujaplicin has been researched along with Liver Neoplasms in 1 studies
beta-thujaplicin: structure
beta-thujaplicin : A monoterpenoid that is cyclohepta-2,4,6-trien-1-one substituted by a hydroxy group at position 2 and an isopropyl group at position 4. Isolated from Thuja plicata and Chamaecyparis obtusa, it exhibits antimicrobial activities.
Liver Neoplasms: Tumors or cancer of the LIVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, G | 1 |
| He, J | 1 |
| Ye, X | 1 |
| Zhu, J | 1 |
| Hu, X | 1 |
| Shen, M | 1 |
| Ma, Y | 1 |
| Mao, Z | 1 |
| Song, H | 1 |
| Chen, F | 1 |
1 other study available for beta-thujaplicin and Liver Neoplasms
| Article | Year |
|---|---|
β-Thujaplicin induces autophagic cell death, apoptosis, and cell cycle arrest through ROS-mediated Akt and p38/ERK MAPK signaling in human hepatocellular carcinoma.
Topics: Aged; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagic Cell Death; Autophagosomes; | 2019 |